Last kr139.00 DKK
Change Today +4.00 / 2.96%
Volume 35.6K
As of 11:02 AM 12/23/14 All times are local (Market data is delayed by at least 15 minutes).

ambu a/s-b (AMBUB) Snapshot

Previous Close
Day High
Day Low
52 Week High
12/23/14 - kr144.50
52 Week Low
12/30/13 - kr72.50
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for AMBU A/S-B (AMBUB)

Related News

No related news articles were found.

ambu a/s-b (AMBUB) Related Businessweek News

No Related Businessweek News Found

ambu a/s-b (AMBUB) Details

Ambu A/S provides healthcare solutions in anesthesia, patient monitoring and diagnostics, and emergency care fields worldwide. The company offers anesthesia products, including laryngeal masks, ventilation bags, face masks for artificial ventilation, scopes for visualization, anesthesia tubes, and pumps for palliative care; patient monitoring and diagnostics products, such as single-use electrodes for neurological and cardiological examinations, and tubes and needles; emergency care products comprising neck collars, manikins, and other equipment for first-aid training; conductive adhesive gels for use in the production of skin-contacting biomedical electrodes; and single-use videoscopes. The company serves hospitals, clinics, rescue services and sleep laboratories, aid organizations, and the armed forces. It sells and exports its products through direct sales and distributors. The company was founded in 1937 and is headquartered in Ballerup, Denmark.

2,341 Employees
Last Reported Date: 11/13/14
Founded in 1937

ambu a/s-b (AMBUB) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

ambu a/s-b (AMBUB) Key Developments

Ambu A/S Announces Dividend for the Year 2013/14

Ambu A/S announced that at its AGM held on December 17, 2014, the distribution of the profit for the year was adopted, and dividend of DKK 3.75 per share will consequently be distributed, corresponding to 30% of the net profit.

Ambu Announces Earnings Results for the Year 2014

Ambu announced earnings results for the year 2014. For the year, the company’ revenue was up 15% at DKK 1,584 million based on organic growth in local currencies of 7%, which is in excess of the normal market growth. Operating income (EBITDA) before special items increased 22% to DKK 286 million compared to DKK 235 million a year ago. EBIT before special items was up at DKK 198 million compared to DKK 161 million a year ago. Free cash flows before acquisitions of companies and before payment of special items thus totaled DKK 114 million compared to DKK 103 million a year ago. Net profit came to DKK 151 million compared to DKK 48 million a year ago.

Ambu A/S, 2014 Earnings Call, Nov 13, 2014

Ambu A/S, 2014 Earnings Call, Nov 13, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMBUB:DC kr139.00 DKK +4.00

AMBUB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Repro-Med Systems Inc $0.40 USD -0.01
View Industry Companies

Industry Analysis


Industry Average

Valuation AMBUB Industry Range
Price/Earnings 43.1x
Price/Sales 4.1x
Price/Book 7.5x
Price/Cash Flow 36.4x
TEV/Sales 2.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMBU A/S-B, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at